Significance of the CAG repeat length in the androgen receptor gene (AR) for the transactivation function of an M780I mutant AR

Human Genetics

Volumn 104, Issue 3, 1999, Pages 257-261

  Knoke, Ingrid ^a   Allera, Axel ^b   Wieacker, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; LUCIFERASE; MUTANT PROTEIN; TRANSACTIVATOR PROTEIN;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR GENE; REPORTER GENE; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; TRINUCLEOTIDE REPEAT;

AMINO ACID SUBSTITUTION; GLUTAMIC ACID; HELA CELLS; HUMANS; LUCIFERASES; MALE; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRINUCLEOTIDE REPEATS;

EID: 0032911050     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390050945     Document Type: Article

References (27)

1. th International Congress on Hormonal Stroids, Abstract 86, 1998
2. Brinkmann AO, Faber PW, Rooig HC van, Kuiper GG, Ris C, Klaassen P, Korpurt JA van der, Voorhorst MM, Laar JH van, Mulder E, et al (1989) The human androgen receptor: domain structure, genomic organization and regulation of expression. J Steroid Biochem 34:307-310
3. Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
4. Chen EY, Seeburg PH (1985) Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA 4:165-170
5. DeBellis A, Quigley CA, Marschke KB, El-Awady MK, Lane MV, Smith EP, Sar M, Wilson EM, French FS (1994) Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome. J Clin Endocrinol Metab 78:513-522
6. Giovannuci E, Stampfer MJ, Kritihvas K, Brown M, Brufsky A, Talcott J, Hennekens CH, Kantoff PW (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 94:3320-3323
7. Gottlieb B, Lehvaslaiko H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M (1998) The androgen receptor gene mutation database. Nucleic Acid Res 26:234-238
8. Hiort O, Huang Q, Sinnecker GH, Sadeghi-Nejad A, Kruse K, Wolfe HJ, Yandell DW (1993) Single strand conformation polymorphism analysis of androgen receptor gene mutations in patients with androgen insensitivity syndromes: application for diagnosis, genetic counseling, and therapy. J Clin Endocrinol Metab 77:262-266
9. Hiort O, Sinnecker GH, Holterhus PM, Nitsche EM, Kruse K (1996) The clinical and molecular spectrum of androgen insensitivity syndromes. Am J Med Genet 63: 218-222
10. th US Endocrinology Society Meeting. Abstracts P2-P38
11. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
12. Lobaccaro JM, Lumbroso S, Berta P, Chaussain JL, Sultan C (1993) Complete androgen insensitivity syndrome associated with a de novo mutation of the androgen receptor gene detected by single strand conformation polymorphism. J Steroid Biochem Mol Biol 44:211-216
13. Marcelli M, Zoppi S, Grino PB, Griffin JE, Wilson JD, McPhaul MJ (1991) A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. J Clin Invest 87:1123-1126
14. McPhaul MJ, Marcelli M, Zoppi S, Wilson CM, Griffin JE, Wilson JD (1992) Mutations in the ligand-binding domain of the androgen receptor gene cluster in two regions of the gene. J Clin Invest 90:2097-2101
15. Morris JM, Mahesh VB (1963) Further observations on the syndrome "testicular feminization". Am J Obstet Gynecol 87:731-748
16. Nakao R, Yanase T, Sakai Y, Haji M, Nawata H (1993) A single amino acid substitution (gly→val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome. J Clin Endocrinol Metab 77:103-107
17. Nordenskjold A, Soderhall S (1998) An androgen receptor gene mutation (A645D) in a boy with normal phenotype. Hum Mutat 11:339
18. Pinsky L, Trifiro M, Kaufman M, Beitel LK, Mhatre A, KazemiEsfarjani P, Sabbaghian N, Lumbroso R, Alvarado C, Vasiliou M, et al (1992) Androgen resistance due to mutation of the androgen receptor. Clin Invest Med 15:456-472
19. Quigley CA, DeBellis A, Marschke KB, El-Awady MK, Wilson EM, French FS (1995) Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16: 271-321
20. Ris-Stalpers C, Trifiro MA, Kuiper GG, Jenster G, Romalo G, Sai T, Rooij HC van, Kaufman M, Rosenfield RL, Liao S, et al (1991) Substitution of aspartic acid-686 by histidine or asparagine in the human androgen receptor leads to a functionally inactive protein with altered hormone-binding characteristics. Mol Endocrinol 5:1562-1569
21. Ris-Stalpers C, Hoogenboezem T, Sleddens HF, Verleun-Mooijman MC, Degenhart HJ, Drop SL, Halley DJ, Oosterwijk JC, Hodgins MB, Trapman J, et al (1994) A practical approach to the detection of androgen receptor gene mutations and pedigree analysis in families with X-linked androgen insensitivity. Pediatr Res 36:227-234
22. Rodien P, Mebarki F, Mowszowicz I, Chaussain JL, Young J, Morel Y, Schaison G (1996) Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metabol 81:2994-2998
23. Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL (1997) Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. J Clin Endocrinol Metab 82:3777-3782
24. Weidemann W, Linck B, Haupt H, Mentrup B, Romalo G, Stocklauser K, Brinkmann AO, Schweikert HU, Spindler KD (1996) Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene. Clin Endocrinol 45:733-739
25. Weidemann W, Peters B, Romalo G, Spindler KD, Schweikert HU (1998) Response to androgen treatment in a patient with partial androgen insensitivity and a mutation in the DNA-binding domain of the androgen receptor. J Clin Endocrinol Metab 83:1173-1176
26. Wolf U (1997) Identical mutations and phenotypic variation. Hum Genet 100:305-321
27. Zoppi S, Marcelli M, Deslypere JP, Griffin JE, Wilson JD, McPhaul MJ (1992) Amino acid substitutions in the DNA-binding domain of the human androgen receptor are a frequent cause of receptor-binding positive androgen resistance. Mol Endocrinol 6:409-415